← Back to Clinical Trials
Recruiting NCT06797492

NCT06797492 Virtual Reality for Shoulder Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06797492
Status Recruiting
Phase —
Sponsor Fondazione Policlinico Universitario Campus Bio-Medico
Condition Shoulder Musculoskeletal Disorders
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-09-01
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Shoulder Physical ExaminationShoulder Rehabilitation in a Virtual EnvironmentUsability assessment and presence and co-presence evaluation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-09-01 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Goal: The clinical investigation involves the evaluation of the usability level of the VR system, sense of presence, and co-presence during the execution of various rehabilitation exercises through specific questionnaires. Participant Population: The study will enroll 50 patients with shoulder musculoskeletal disorders will be enrolled Main Questions: * How does the integration of Virtual Reality (VR) in rehabilitation programs impact the usability of the system for patients with shoulder musculoskeletal disorders? * To what extent does the sense of presence experienced by patients using VR systems influence their motivation and adherence to rehabilitation exercises? * How do patients with shoulder musculoskeletal disorders perceive the co-presence in VR rehabilitation scenarios, and how does it affect their overall treatment experience? Participant Tasks: * Shoulder Physical Examination * Instructions to the patient on exercises to be performed using Oculus and selection of customizable settings on the VR app * Execution of the protocol developed for shoulder rehabilitation in a virtual environment * Evaluation of the usability of the VR system, sense of presence, and co-presence through different validated scales

Eligibility Criteria

Inclusion Criteria: * Patients with shoulder musculoskeletal disorders * Patients aged 18-75 years * Patients who have signed informed consent Exclusion Criteria: * Patients with insufficient cognitive and language functions to follow instructions provided by clinicians and/or experimenters involved in the project * Patients who do exhibit impediments that could hinder the use of VR devices

Contact & Investigator

Central Contact

Umile Giuseppe Longo, MD, MSc, PhD

✉ g.longo@policlinicocampus.it

📞 : +39 06225418816

Frequently Asked Questions

Who can join the NCT06797492 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Shoulder Musculoskeletal Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06797492 currently recruiting?

Yes, NCT06797492 is actively recruiting participants. Contact the research team at g.longo@policlinicocampus.it for enrollment information.

Where is the NCT06797492 trial being conducted?

This trial is being conducted at Roma, Italy, Rome, Italy.

Who is sponsoring the NCT06797492 clinical trial?

NCT06797492 is sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology